vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and CHAIN BRIDGE BANCORP INC (CBNA). Click either name above to swap in a different company.

Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $14.7M, roughly 1.3× CHAIN BRIDGE BANCORP INC). CHAIN BRIDGE BANCORP INC runs the higher net margin — 36.4% vs -6.8%, a 43.1% gap on every dollar of revenue. CHAIN BRIDGE BANCORP INC produced more free cash flow last quarter ($11.5M vs $-2.8M).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Suburban Bancorp, Inc. was a publicly traded multibank holding company headquartered in suburban Chicago. It was founded by Gerald F. Fitzgerald, father of former U.S. Senator Peter Fitzgerald, and majority owned by the Fitzgerald family. Bank of Montreal acquired Suburban Bancorp, Inc. by merger in 1994. Harris Bankmont, Inc., an American subsidiary of Bank of Montreal, merged with Suburban Bankcorp to expand the Harris Bank presence in the Chicago area. The all-stock deal was valued at $246...

APYX vs CBNA — Head-to-Head

Bigger by revenue
APYX
APYX
1.3× larger
APYX
$19.2M
$14.7M
CBNA
Higher net margin
CBNA
CBNA
43.1% more per $
CBNA
36.4%
-6.8%
APYX
More free cash flow
CBNA
CBNA
$14.3M more FCF
CBNA
$11.5M
$-2.8M
APYX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
CBNA
CBNA
Revenue
$19.2M
$14.7M
Net Profit
$-1.3M
$5.3M
Gross Margin
62.6%
Operating Margin
0.1%
45.6%
Net Margin
-6.8%
36.4%
Revenue YoY
34.7%
Net Profit YoY
71.9%
EPS (diluted)
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
CBNA
CBNA
Q4 25
$19.2M
$14.7M
Q3 25
$12.9M
$13.1M
Q2 25
$11.4M
$12.6M
Q1 25
$9.4M
$14.5M
Q4 24
$14.2M
Q3 24
$11.5M
$16.7M
Q2 24
$12.1M
Q1 24
$10.2M
Net Profit
APYX
APYX
CBNA
CBNA
Q4 25
$-1.3M
$5.3M
Q3 25
$-2.0M
$4.7M
Q2 25
$-3.8M
$4.6M
Q1 25
$-4.2M
$5.6M
Q4 24
$-4.6M
Q3 24
$-4.7M
$7.5M
Q2 24
$-6.6M
Q1 24
$-7.6M
Gross Margin
APYX
APYX
CBNA
CBNA
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
CBNA
CBNA
Q4 25
0.1%
45.6%
Q3 25
-6.5%
44.9%
Q2 25
-22.6%
45.8%
Q1 25
-32.4%
48.4%
Q4 24
-21.4%
Q3 24
-31.6%
56.3%
Q2 24
-45.7%
Q1 24
-64.6%
Net Margin
APYX
APYX
CBNA
CBNA
Q4 25
-6.8%
36.4%
Q3 25
-15.4%
35.8%
Q2 25
-33.2%
36.3%
Q1 25
-44.0%
38.6%
Q4 24
-32.5%
Q3 24
-40.9%
44.8%
Q2 24
-54.0%
Q1 24
-74.0%
EPS (diluted)
APYX
APYX
CBNA
CBNA
Q4 25
$0.81
Q3 25
$0.72
Q2 25
$0.70
Q1 25
$0.85
Q4 24
Q3 24
$1.64
Q2 24
$-0.19
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
CBNA
CBNA
Cash + ST InvestmentsLiquidity on hand
$31.7M
$586.6M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$169.2M
Total Assets
$66.8M
$1.8B
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
CBNA
CBNA
Q4 25
$31.7M
$586.6M
Q3 25
$25.1M
$395.7M
Q2 25
$29.3M
$377.3M
Q1 25
$31.0M
$629.2M
Q4 24
$31.7M
Q3 24
$28.0M
$639.8M
Q2 24
$32.7M
Q1 24
$37.3M
Total Debt
APYX
APYX
CBNA
CBNA
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
CBNA
CBNA
Q4 25
$14.5M
$169.2M
Q3 25
$5.8M
$163.1M
Q2 25
$7.3M
$156.9M
Q1 25
$10.5M
$151.5M
Q4 24
$14.2M
Q3 24
$11.0M
$104.8M
Q2 24
$14.7M
Q1 24
$20.3M
Total Assets
APYX
APYX
CBNA
CBNA
Q4 25
$66.8M
$1.8B
Q3 25
$57.4M
$1.5B
Q2 25
$58.2M
$1.4B
Q1 25
$60.2M
$1.7B
Q4 24
$64.8M
Q3 24
$60.7M
$1.6B
Q2 24
$65.4M
Q1 24
$70.7M
Debt / Equity
APYX
APYX
CBNA
CBNA
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
CBNA
CBNA
Operating Cash FlowLast quarter
$-2.5M
$15.6M
Free Cash FlowOCF − Capex
$-2.8M
$11.5M
FCF MarginFCF / Revenue
-14.6%
78.1%
Capex IntensityCapex / Revenue
1.4%
28.0%
Cash ConversionOCF / Net Profit
2.92×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$17.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
CBNA
CBNA
Q4 25
$-2.5M
$15.6M
Q3 25
$-3.5M
$2.8M
Q2 25
$-1.2M
$3.4M
Q1 25
$-702.0K
$3.1M
Q4 24
$-2.9M
Q3 24
$-4.4M
Q2 24
$-4.3M
Q1 24
$-6.3M
Free Cash Flow
APYX
APYX
CBNA
CBNA
Q4 25
$-2.8M
$11.5M
Q3 25
$-4.1M
$2.5M
Q2 25
$-1.5M
$2.5M
Q1 25
$-757.0K
$1.4M
Q4 24
$-3.2M
Q3 24
$-4.6M
Q2 24
$-4.6M
Q1 24
$-6.4M
FCF Margin
APYX
APYX
CBNA
CBNA
Q4 25
-14.6%
78.1%
Q3 25
-31.5%
18.7%
Q2 25
-13.2%
20.0%
Q1 25
-8.0%
9.8%
Q4 24
-22.4%
Q3 24
-40.0%
Q2 24
-38.0%
Q1 24
-62.2%
Capex Intensity
APYX
APYX
CBNA
CBNA
Q4 25
1.4%
28.0%
Q3 25
4.0%
2.5%
Q2 25
2.3%
6.5%
Q1 25
0.6%
11.6%
Q4 24
1.7%
Q3 24
1.3%
Q2 24
2.4%
Q1 24
0.3%
Cash Conversion
APYX
APYX
CBNA
CBNA
Q4 25
2.92×
Q3 25
0.59×
Q2 25
0.73×
Q1 25
0.55×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons